STAT1 has been reported to be protective in gastric cancer (98), liver cancer (99), and melanoma (100), but hazardous in glioblastoma (101) and sarcoma (102), and controversial in breast (103–106) and pancreatic cancer. This evidence concerns the gene STAT1 and familial pancreatic carcinoma.